Home / Research / The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.

The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.

Authors: Jetly R1, Heber A2, Fraser G3, Boisvert D3.

Abstract

OBJECTIVE:

Investigate the efficacy of nabilone capsules (NAB) in reducing the frequency and intensity of nightmares in subjects with PTSD.

PATIENTS AND METHODS:

Canadian male military personnel with PTSD, who despite standard treatment continued to experience trauma-related nightmares, received double-blind treatment with 0.5mg NAB or placebo (PBO), and then titrated to the effective dose (nightmare suppression) or reaching a maximum of 3.0mg. Subjects were followed for 7 weeks and then, following a 2-week washout period, were titrated with the other study treatment and followed for an additional 7 weeks. The modified intent-to-treat (mITT) population, which included all treated subjects that met inclusion/exclusion criteria, was analyzed.

RESULTS:

Ten subjects were included in the mITT population. The mean reduction in nightmares as measured by the CAPS Recurring and Distressing Dream scores were -3.6 ± 2.4 and -1.0 ± 2.1 in the NAB and PBO groups, respectively (p=0.03). Mean global improvement as measured by the Clinical Global Impression of Change (CGI-C) was 1.9 ± 1.1 (i.e. much improved) and 3.2 ± 1.2 (i.e. minimally improved) in the NAB and PBO groups, respectively (p=0.05) Five out of 10 (50%) were much improved on NAB versus 1 out of 9 (11%) on PBO. Results for the General Well Being Questionnaire (WBQ) were 20.8 ± 22 and -0.4 ± 20.6 in the NAB and PBO groups, respectively (p=0.04). The proportion of subjects who experienced a treatment-related occurrence of adverse events was 50% in the NBO group and 60% in the PBO group. No event was severe nor resulted in a drop-out. This study is registered with Health Canada.

CONCLUSION:

In this small sample NAB provided significant relief for military personnel with PTSD, indicating that it shows promise as a clinically-relevant treatment for patients with nightmares and a history of non-response to traditional therapies. These findings need to be replicated in a larger cohort. There is a need for further exploration of the effect of nabilone on other symptoms of PTSD such as re-experiencing, hyper vigilance and insomnia.

Article found on PubMed

Full article available for purchase here.

 

Top

WordPress database error: [Table './mcawaren_wp/wp_woocommerce_sessions' is marked as crashed and should be repaired]
INSERT INTO wp_woocommerce_sessions (`session_key`, `session_value`, `session_expiry`) VALUES ('5f3b1eb554eceacb7bb8491eb8a2033d', 'a:7:{s:4:\"cart\";s:6:\"a:0:{}\";s:11:\"cart_totals\";s:367:\"a:15:{s:8:\"subtotal\";i:0;s:12:\"subtotal_tax\";i:0;s:14:\"shipping_total\";i:0;s:12:\"shipping_tax\";i:0;s:14:\"shipping_taxes\";a:0:{}s:14:\"discount_total\";i:0;s:12:\"discount_tax\";i:0;s:19:\"cart_contents_total\";i:0;s:17:\"cart_contents_tax\";i:0;s:19:\"cart_contents_taxes\";a:0:{}s:9:\"fee_total\";i:0;s:7:\"fee_tax\";i:0;s:9:\"fee_taxes\";a:0:{}s:5:\"total\";i:0;s:9:\"total_tax\";i:0;}\";s:15:\"applied_coupons\";s:6:\"a:0:{}\";s:22:\"coupon_discount_totals\";s:6:\"a:0:{}\";s:26:\"coupon_discount_tax_totals\";s:6:\"a:0:{}\";s:21:\"removed_cart_contents\";s:6:\"a:0:{}\";s:8:\"customer\";s:691:\"a:26:{s:2:\"id\";s:1:\"0\";s:13:\"date_modified\";s:0:\"\";s:8:\"postcode\";s:0:\"\";s:4:\"city\";s:0:\"\";s:9:\"address_1\";s:0:\"\";s:7:\"address\";s:0:\"\";s:9:\"address_2\";s:0:\"\";s:5:\"state\";s:2:\"MB\";s:7:\"country\";s:2:\"NZ\";s:17:\"shipping_postcode\";s:0:\"\";s:13:\"shipping_city\";s:0:\"\";s:18:\"shipping_address_1\";s:0:\"\";s:16:\"shipping_address\";s:0:\"\";s:18:\"shipping_address_2\";s:0:\"\";s:14:\"shipping_state\";s:2:\"MB\";s:16:\"shipping_country\";s:2:\"NZ\";s:13:\"is_vat_exempt\";s:0:\"\";s:19:\"calculated_shipping\";s:0:\"\";s:10:\"first_name\";s:0:\"\";s:9:\"last_name\";s:0:\"\";s:7:\"company\";s:0:\"\";s:5:\"phone\";s:0:\"\";s:5:\"email\";s:0:\"\";s:19:\"shipping_first_name\";s:0:\"\";s:18:\"shipping_last_name\";s:0:\"\";s:16:\"shipping_company\";s:0:\"\";}\";}', 1542799543) ON DUPLICATE KEY UPDATE `session_value` = VALUES(`session_value`), `session_expiry` = VALUES(`session_expiry`)